Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
438
-
Total 13F shares, excl. options
-
57.4M
-
Shares change
-
+1.19M
-
Total reported value, excl. options
-
$7.3B
-
Value change
-
+$139M
-
Put/Call ratio
-
8.01
-
Number of buys
-
227
-
Number of sells
-
-173
-
Price
-
$127.24
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2025
502 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2025.
REPLIGEN CORP - COMMON STOCK (RGEN) has 438 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.4M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.57M shares), BlackRock, Inc. (6.82M shares), VANGUARD GROUP INC (5.08M shares), STATE STREET CORP (1.69M shares), Invesco Ltd. (1.67M shares), Champlain Investment Partners, LLC (1.46M shares), Bank of New York Mellon Corp (1.35M shares), CITADEL ADVISORS LLC (1.33M shares), SANDS CAPITAL MANAGEMENT, LLC (1.29M shares), and Point72 Asset Management, L.P. (1.12M shares).
This table shows the top 438 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.